Economic benefits of optimizing anchor therapy for rheumatoid arthritis

Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

(2010) S. L. Gorter et al.   ANNALS OF THE RHEUMATIC DISEASES

Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

(2010) M. Schoels et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis

(2010) F. Buttgereit et al.   ANNALS OF THE RHEUMATIC DISEASES

Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: Meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons

(2010) Niels Graudal et al.   ARTHRITIS AND RHEUMATISM

Body mass index and clinical response to infliximab in rheumatoid arthritis

(2010) Ruth Klaasen et al.   ARTHRITIS AND RHEUMATISM

Hypothalamus-Pituitary-Adrenal Axis Function in Patients with Rheumatoid Arthritis Treated with Nighttime-Release Prednisone

(2010) R. ALTEN et al.   JOURNAL OF RHEUMATOLOGY

BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy

(2010) C. Deighton et al.   RHEUMATOLOGY

Decrease in orthopaedic operations, including total joint replacements, in patients with rheumatoid arthritis between 2001 and 2007: data from Japanese outpatients in a single institute-based large observational cohort (IORRA)

(2009) S Momohara et al.   ANNALS OF THE RHEUMATIC DISEASES

Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database

(2009) T Sokka et al.   ANNALS OF THE RHEUMATIC DISEASES

Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis

(2009) L. H. D. van Tuyl et al.   ANNALS OF THE RHEUMATIC DISEASES

The cost-utility analysis of the BeSt trial: Is a camel in fact a horse with abnormalities in the distribution of dorsal fat? Comment on the article by van den Hout et al

(2009) Maarten Boers   ARTHRITIS AND RHEUMATISM

Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis

(2009) Wilbert B. Van den Hout et al.   ARTHRITIS AND RHEUMATISM

Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis

(2009) V. Ravindran et al.   RHEUMATOLOGY

Disease status, costs and quality of life of patients with rheumatoid arthritis in France: The ECO-PR Study

(2008) Gisela Kobelt et al.   JOINT BONE SPINE

Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial

(2008) Frank Buttgereit et al.   LANCET